Stephens raised the firm’s price target on Alignment Healthcare to $7 from $6 and keeps an Equal Weight rating on the shares. The company’s Q1 results give the firm more confidence in the EBITDA break-even target, the analyst tells investors in a post-earnings note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALHC:
- Alignment Healthcare price target lowered to $9 from $11 at Stifel
- Alignment Healthcare to Announce First Quarter 2024 Financial Results and Host Conference Call Thursday, May 2, 2024
- Insurer stocks tumble as Medicare Advantage rates disappoint
- CMS finalizes payment update for 2025 Medicare Advantage, sees payments up 3.7%
- Alignment Healthcare to Participate in a Virtual Fireside hosted by Raymond James